Mundisal (Choline Salicylate)

Choline Salicylate, the active ingredient in Mundisal, is a salicylate presented as a topical solution for nasal, oromucosal and oropharyngeal use. It provides analgesic and anti‑inflammatory relief for discomfort in the mouth, throat and nasal passages.\n\nGNH India supplies Mundisal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Choline Salicylate acts on prostaglandin‑mediated pain and inflammation pathways, making it useful for several localized discomforts.\n\n- Mild to moderate oral pain: reduces pain and inflammation in the mouth and throat.\n- Inflammatory oral lesions: eases swelling and discomfort associated with aphthous ulcers or trauma.\n- Nasal irritation or mild sinus discomfort: alleviates pain and local inflammation in the nasal mucosa.

Adverse reactions may occur at the site of application or systemically, although most are mild and reversible.\n\nCommon Side Effects:\n- Local burning or stinging sensation\n- Taste alteration or metallic taste\n- Mild nasal irritation or dryness\n- Transient headache\n- Mild gastrointestinal discomfort if swallowed\n\nSerious or Rare Side Effects:\n- Allergic reactions such as rash, pruritus or angioedema\n- Stevens‑Johnson syndrome or toxic epidermal necrolysis\n- Severe gastrointestinal bleeding\n- Hepatic dysfunction in susceptible individuals\n- Hematologic abnormalities such as thrombocytopenia

Before using Mundisal, consider the following safety measures.\n\n- Pregnancy: consult a healthcare professional before use.\n- Bleeding disorders: avoid or use with caution due to antiplatelet effects.\n- Asthma or aspirin‑sensitive respiratory disease: may exacerbate symptoms.\n- Concomitant NSAIDs or other salicylates: increased risk of toxicity.\n- Renal impairment: monitor renal function during prolonged use.\n- Store at ambient temperature: keep in the original container, protect from moisture and light.

Choline Salicylate can interact with several drug classes; awareness helps minimize risk.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin): heightened bleeding risk.\n- Other salicylates or NSAIDs: additive gastrointestinal and bleeding toxicity.\n\nModerate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: possible reduction in renal function.\n- Diuretics: may increase risk of renal impairment.\n- Methotrexate: potential for increased methotrexate toxicity.